参考文献/References:
[1] 黄从新,张澍,黄德嘉,等.心房颤动:目前的认识和治疗建议2018[J].中国心脏起搏与心电生理杂志,2018,32(4):315-367[2] 董佳佳,程康安.亚临床心房颤动的认识与进展[J].中国心血管杂志,2017,22(5):373-376.
[3] Haissaguerre MJais P,Shah DC,et al.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J].N Engl J Med,1998,339(10): 659-666.
[4] Ellis CR,Saavedra P,Kanagasundram A,et al.Pulmonary vein sleeve length and association with body mass index and sex in atrial fibrillation[J].JACC Clin Electrophysiol,2018,4(3):412-414.
[5] Johannes S,Silver M,Reza W.Pulmonary vein isolation with the multipolar nMARQ? ablation catheter: efficacy and safety in acute and long-term follow up[J].J Atr Fibrillation,2017,9(6):1600.
[6] Tsuneoka Y,Irie M,Tanaka Y,et al.Permissive role of reduced inwardly-rectifying potassium current density in the automaticity of the guinea pig pulmonary vein myocardium[J].J Pharmacol Sci,2017,133(4):195-202.
[7] Xiao Y,Cai X,Atkinson A,et al.Expression of connexin 43,ion channels and Ca2+-handling proteins in rat pulmonary vein cardiomyocytes[J].Exp Ther Med,2016,12(5):3233-3241.
[8] Pappone C,Rosanio S,Oreto G,et al.Circumferential radiofrequency ablation of pulmonary vein ostia:a new anatomic approach for curing atrial fibrillation[J].Circulation,2000,102(21): 2619-2628.
[9] Ouyang F,Ernst S,Chun J,et al.Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique[J].Circulation,2005,112(20): 3038-3048.
[10] Qin M,Zeng C,Liu X.The cardiac autonomic nervous system:a target for modulation of atrial fibrillation[J].Clin Cardiol,2019,42(6):644-652.
[11] Giannopoulos G,Kossyvakis C,Angelidis C,et al.Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence[J].Europace,2017,19(12):1967-1972.
[12] Yu X,Lu Z,He W,et al.Cardiac autonomic ganglia ablation suppresses atrial fibrillation in a canine model of acute intermittent hypoxia[J].Auton Neurosci, 2017,205:26-32.
[13] Buckley U,Rajendran PS,Shivkumar K.Ganglionated plexus ablation for atrial fibrillation: Just because we can,does that mean we should?[J].Heart Rhythm,2017,14(1):133-134.
[14] Carnagarin R,Kiuchi MG,Ho JK,et al.Sympathetic nervous system activation and its modulation: role in atrial fibrillation[J].Front Neurosci,2019,12:1058.
[15] TanAY,Li H,Wachsmann-Hogiu S,et al.Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction:implications for catheter ablation of atrial-pulmonaryveinjunction[J].J Am Coll Cardiol,2006,48(1): 132-143.
[16] Kampaktsis PN,Oikonomou EK,Y Choi D,et al.Efficacy of ganglionated plexi ablation in addition to pulmonary vein isolation for paroxysmal versus persistent atrial fibrillation: a meta-analysis of randomized controlled clinical trials[J].J Interv Card Electrophysiol,2017,50(3):253-260.
[17] Choi E,Chen P.Is the atrial neural plexis a therapeutic target in atrial fibrillation? [J].Methodist Debakey Cardiovasc J, 2015,11(2):82-86.
[18] Katritsis DG,Pokushalov E,Romanov A,et al.Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation[J].J Am Coll Cardiol, 2013,62(24):2318-2325.
[19] Choi EK,Zhao Y,Everett TH 4th,et al.Ganglionated plexi as neuromodulation targets for atrial fibrillation[J].J Cardiovasc Electrophysiol,2017,28(12):1485-1491.
[20] Stavrakis S,Po S.Ganglionated plexi ablation:physiology and clinical applications[J].Arrhythm Electrophysiol Rev, 2017,6(4):186-190.
[21] Scanavacca M,Pisani CF,Hachul D,et al.Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation[J].Circulation,2006,114(9):876-885.
[22] Pappone C,Santinelli V,Manguso F,et al.Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation[J].Circulation,2004,109(3):327-334.
[23] Pokushalov E,Romanov A,Artyomenko S,et al.Ganglionated plexi ablation for longstanding persistent atrial fibrillation[J].Europace,2010,12(3): 342-346.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(12):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(12):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(12):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(12):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(12):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(12):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
[12]赵磊 梁兆光.导管消融术后心房颤动复发的危险因素及预防[J].心血管病学进展,2019,(5):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
ZHAO LeiLIANG Zhaoguang.Risk Factors and Prevention of Atrial Fibrillation Recurrence after Catheterablation[J].Advances in Cardiovascular Diseases,2019,(12):766.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.025]
[13]辛小宇 梁兆光.心房颤动导管消融围术期抗凝治疗研究进展[J].心血管病学进展,2020,(8):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
XIN XiaoyuLIANG Zhaoguang.Perioperative Anticoagulation for Atrial Fibrillation Catheter Ablation[J].Advances in Cardiovascular Diseases,2020,(12):809.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.007]
[14]刘玉辉 王盼盼 陈椿.心房颤动性心肌病临床研究进展[J].心血管病学进展,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
LIU Yuhui,WANG Panpan,CHEN Chun.Atrial Fibrillation-induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(12):1238.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.004]
[15]白金龙 李洪仕 蔡衡.非瓣膜性心房颤动导管消融术后抗凝策略的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.201.01.000]
[16]那丞 黄织春.干预自主神经对心房颤动影响的研究进展[J].心血管病学进展,2021,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
NA Cheng,HUANG Zhichun.Effect of Autonomic Nerve Intervention on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(12):30.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[17]徐尧 蔡衡 李洪仕.心房颤动合并心力衰竭的导管消融治疗[J].心血管病学进展,2021,(4):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
XU Yao,CAI Heng,LI Hongshi.Role of Radiofrequency Ablation in Patients with Atrial Fibrillation and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(12):322.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.009]
[18]袁明 谢瑞芹.导管消融对心房颤动患者生活质量影响的研究进展[J].心血管病学进展,2021,(10):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
YUAN MingXIE Ruiqin.Effect of Catheter Ablation on Quality of Life in patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(12):884.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.005]
[19]邹永伟 胡小恋.左房低电压与心房颤动相关性的研究进展[J].心血管病学进展,2022,(3):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
ZHOU Yongwei,H U Xiaolian.The Correlation Between Left Atrial Low-Voltage Area and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(12):211.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[20]李珂 赵海娟 赵耀 黄松群 郭志福.肥厚型心肌病合并心房颤动的导管消融[J].心血管病学进展,2022,(5):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]
LI Ke,ZHAO Haijuan,ZHAO Yao,et al.Catheter Ablation of Hypertrophic Cardiomyopathy with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(12):399.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.004]